KELER TIBOR 4
4 · Celldex Therapeutics, Inc. · Filed Jun 15, 2018
Insider Transaction Report
Form 4
KELER TIBOR
Sr. VP & CSO
Transactions
- Award
Incentive Stock Option (right to buy)
2018-06-13+390,000→ 390,000 totalExercise: $0.60From: 2019-06-13Exp: 2028-06-13→ Common Stock (390,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.
- [F2]25% vest on June 13, 2019 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.